About
Jil advises on national and international corporate transactions and general corporate matters.
She speaks German and English.
Additional Information
- Veloxis and Asahi Kasei on the acquisition of AiCuris Anti-infective Cures AG
- Evotec SE on (I) the sale of its Just - Evotec Biologics to Sandoz AG; (ii) on the acquisition of Italian cell therapy company Rigenerand Srl; and (iii) on the acquisition of Central Glass Germany
- Grünenthal on a collaboration with Kyowa Kirin International regarding Kyowa Kirin’s established medicines portfolio
- Merck on the sale of its Surface Solutions Business to Global New Material International Holdings Ltd.
- Eppendorf on the sale of its micro manipulation product portfolio to Calibre Scientific (USA)
- Otto Bock Holding on (i) on its sale of 20 per cent of Otto Bock HealthCare GmbH to EQT; and (ii) the agreement with Allgeier to merge their SAP and Microsoft business units
- H.I.G. Capital on (i) the acquisition of Lagardère Sports; and (ii) on the acquisition of Beinbauer group
- The purchaser on the acquisition of “The Squaire”
- A consortium of Chinese investors on the acquisition of HTC group
- Hellman & Friedman on the business combination of their portfolio company Nets /AS with Concardis Payment Group
- Cinven on the acquisition of Generali Lebensversicherung AG
- Nordic Capital on the acquisition of a European dental business
- Carlyle Investment Management LLC on the acquisition of Atotech
- RHI AG on the acquisition of a controlling stake (at least 46 per cent) in Brazilian Magnesita Refratários (Magnesita)
- Hexion Specialty Chemicals GmbH on the sale of its Performance Adhesives & Coatings business to Synthomer
Dr. Jil Rollmann
Principal Associate
Hamburg Office
Hohe Bleichen 7
Hamburg 20354